openPR Logo
Press release

CEA-Leti Forms Common Lab with IPDiA to Focus on 3D-Integration Technologies for Passive Components on Silicon

03-22-2011 05:51 PM CET | Industry, Real Estate & Construction

Press release from: IPDiA

GRENOBLE, France – March 21st, 2011 – CEA-Leti and IPDiA have formed a common lab to capitalize on their complementary expertise in miniaturization and 3D integration on silicon.

The common lab is dedicated to developing new 3D-integration technologies for passive electronics components on silicon and will open the door to new applications in promising markets such as LED lighting, healthcare and aerospace that require extreme miniaturization. The partnership also will pave the way to improved miniaturization of passive components such as resistors, capacitors and inductors.

Specifically, the common lab is designed to develop:
Very high-end passive components on silicon that will resist harsh environments
Functional sub-mounts for lighting components
Innovative assembly technologies allowing ultra-miniaturization of future products

IPDiA was founded in 2009 to commercialize innovative 3D technologies for integrating passive components. The company’s two axes of focus are integrated devices for high brightness LEDs and integrated passive devices for new medical, industrial, aerospace and defense markets.

CEA-Leti’s expertise in 3D technologies will allow IPDiA to go beyond the third generation of Passive Integration Connecting Substrate (PICS) components (250nF/mm²), which are being produced at IPDiA’s Caen site, and pursue the development of a future generation of PICS components (1µF/mm², then 2µF/mm²) and their assembly.

These products are designed, developed and manufactured by IPDiA in its production unit.

“The technologies to be developed in the common lab are one of the corner stones for industrial development of IPDiA, and our competencies in developing passive components in silicon will allow us to put a real industrial and independent offer in place,” said Franck Murray, CEO of IPDIA. “This partnership is also the result of a great human adventure, a common work between teams from various backgrounds generating creativity and new ideas.”

“This collaboration is in line with Leti’s strategy of working with innovative partners to develop and commercialize new technologies, it and will allow us to position ourselves in the front line of high-performance passive components on silicon

interposers,” said Leti CEO Laurent Malier. “Our complementary competencies in materials and 3D-silicon integration bring strong added value to this common lab.”

About CEA-Leti
CEA is a French research and technology organization, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security. Within CEA, the Laboratory for Electronics & Information Technology (CEA-Leti) works with companies in order to increase their competitiveness through technological innovation and transfers. CEA-Leti is focused on micro and nanotechnologies and their applications, from wireless devices and systems, to biology and healthcare or photonics. Nanoelectronics and microsystems (MEMS) are at the core of its activities. As a major player in MINATEC campus, CEA-Leti operates 8,000-m² state-of-the-art clean rooms, on 24/7 mode, on 200mm and 300mm wafer standards. With 1,200 employees, CEA-Leti trains more than 190 Ph.D. students and hosts 200 assignees from partner companies. Strongly committed to the creation of value for the industry, CEA-Leti puts a strong emphasis on intellectual property and owns more than 1,700 patent families.
Visit www.leti.fr.

Press Contacts

CEA-Leti
Thierry Bosc
+33 4 38 78 31 95
thierry.bosc@cea.fr

Agency
Amélie Ravier
+33 1 58 18 59 30
raviera@loomisgroup.com

IPDiA
Laëtitia Omnès
+33 2 31 53 54 06
laetitia.omnes@ipdia.com

About IPDIA
Founded in June 2009, IPDiA is a leader in passive-components integration on silicon with a global offer for miniaturization that features high-level technological and economic performance. The company is mainly focused on the following fields: healthcare, lighting, communication, defense, aerospace, industry and automotive.
The company is based in Caen, France.

For more information, visit: www.ipdia.com.

IPDiA
2 rue de la Girafe
14000 Caen
France

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CEA-Leti Forms Common Lab with IPDiA to Focus on 3D-Integration Technologies for Passive Components on Silicon here

News-ID: 167576 • Views:

More Releases from IPDiA

Latest news reports on the IPDiA-Leti Common Lab results
Leti and IPDiA are proud to unveil a new worldwide record in capacitance density GRENOBLE, France – April 10, 2012 – CEA-Leti and IPDiA report to overcome a crucial step toward market deployment of a new generation of 3D high-density capacitor achieving 550nF/mm2. In less than two years, CEA-Leti and IPDiA, within the PRIIM project funded by OSEO, are successfully developing a new process based on deposition of atomic medium-K
IPDiA and TecStar/Macnica announce Distribution Agreement for Japan
IPDiA is pleased to announce that a distribution agreement has been signed with TecStar Company (division company of Macnica, Inc.) to offer a wider availability of IPDiA portfolio of high performance silicon passive components in Japan. After Americas and Europe, IPDiA strengthens its sales network in Asia with one of the leaders in electronic components. This agreement implies the distribution of the wide range of IPDiA silicon capacitors and passive networks
Advanced market chip-set solution for RF ISM range 868MHz & 915MHz
Advanced market chip-set solution for RF ISM range 868MHz & 915MHz
IPDiA, a leading supplier of Silicon passive components, today introduced a new generation of RF companion chip products, expanding its product portfolio in high-density Integrated Passive Devices. ASPICS320.604, 605& 606 Integrated Passive Devices (RF ISM range 868MHz & 915MHz) are specifically designed for use with the SX1211 transceiver from Semtech, a leading supplier of analog and mixed-signal semiconductors. The RF design is well known for its complexity and multi influence on

More Releases for Leti

Food Allergy Immunotherapies Market 2022 Precise Outlook - Anergis, HAL Allergy …
Food Allergy Immunotherapies Market Report is an in-depth study of the current state aimed at the major drivers, market strategies, and key player's growth. The study also involves the important Achievements of the market, Research & Development, new product launch, product responses and regional growth of the leading competitors operating in the market on a universal and local scale. The structured analysis contains graphical as well as a diagrammatic representation
Food Allergy Market 2021 Global Key Players – Anergis, HAL Allergy Group, Merc …
Food Allergy Market 2021-2028 New Study Reports " Food Allergy Market 2021 Global Market Opportunities, Challenges, Strategies and Forecasts 2028" has been Added on ResearchNReports. Introduction/Report Summary: This report provides in depth study of “Food Allergy Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Food Allergy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of
Neuromorphic Computing Market Boom Gathers Pace 2021-2027 | Hewlett-Packard, Sam …
The Neuromorphic Computing Market is expected to be valued at USD XX thousand in 2020 and is expected to reach USD 550,593 thousand by 2027, at a CAGR of 89.1% between 2021 and 2027. Every possible effort has been made when research & analysis is performed to prepare this finest Neuromorphic Computing market research report. All statistical & numerical data is interpreted with the use of established & advanced tools such
What's Operating the Allergy Immunotherapy Market, Worldwide Industry Growth?  …
Increasing incidences of allergies and inefficient treatment methodologies, such as pharmacotherapy, for controlling the occurrence rate of allergies are fuelling adoption of allergy immunotherapy, which is deemed as a designated cure for various types of allergies. A notable shift of patients and healthcare providers towards allergy immunotherapy has been observed, owing to its competency to change the course of the disease and improve the immunological resistance. Development of new products to
Allergy Immunotherapies (Allergy Immunotherapy) Market Research Report, Global F …
UpMarketResearch offers a latest published report on “Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report focuses on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get Free Exclusive PDF Sample Copy of This Report @ https://www.upmarketresearch.com/home/requested_sample/27936 Allergy Immunotherapies (Allergy Immunotherapy) Market research report delivers a close watch
Competitive Scenario: Allergy Immunotherapy Market By Key Players: HAL, WOLW Pha …
Qyresearchreports include new market research report Allergy Immunotherapy to its huge collection of research reports. Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change